Mirati Therapeutics (MRTX) Announces CEO Departure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
- Oppenheimer sees AI software winners as focus shifts to ROI
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
Mirati Therapeutics Announces Departure of Chief Executive Officer David Meek
August 8, 2023 4:00 PM EDTCharles M. Baum, M.D., Ph.D. assumes role of interim CEO
SAN DIEGO, Aug. 8, 2023 /PRNewswire/ -- Mirati Therapeutics,... More
